Randomized Trial of Standard Chemotherapy Alone or Combined with Atezolizumab as Adjuvant Therapy for Patients with Stage III Colon Cancer and Deficient DNA Mismatch Repair

Brief Summary

Type:
Colon

Study Type:
Treatment

Phase:
III

ClinicalTrials.gov Identifier:
NCT02912559

Study #:
STUDY00141801

Start Date:
Jan 24, 2018

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT02912559

View Complete Trial Details & Eligibility at ClinicalTrials.gov